Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2018

14.11.2017 | Urologic Oncology

Perioperative Complications and Mortality in Patients with Urothelial Carcinoma and End-Stage Renal Disease Undergoing One-Stage Complete Urinary Tract Extirpation

verfasst von: Yun-Ching Huang, MD, PhD, Ying-Hsu Chang, MD, Alan W. Shindel, MD, Yin-Lun Chang, MD, Jian-Hui Lin, MD, Dong-Ru Ho, MD, Chih-Shou Chen, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Complete urinary tract extirpation (CUTE) is a complex procedure with substantial risk for perioperative complications. The association between clinical characteristics and the risk of major postoperative complications has not been systematically investigated.

Objective

The aim of this study was to analyze the incidence and risks for major perioperative complications after CUTE.

Methods

Respective chart review of 81 patients with urothelial carcinoma (UC) who were treated with one-stage CUTE between January 2004 and December 2015. Fisher’s exact test with Chi square and two-tailed t test were used in categorical and continuous variables, respectively. Univariable and multivariable logistic regression models were used to evaluate the probability of major complications.

Results

In this population, 53 (65.4%) patients had Clavien grade 0–2 complications (‘no major complications’) and 28 (34.6%) patients had Clavien grade 3–5 complications (‘major complications’). Compared with the major complications group, patients in the no major complications group were younger, had lower Charlson Comorbidity Index (CCI), higher preoperative serum albumin, and shorter duration of hospitalization (p < 0.05 for all). Major complications were more common in low-volume surgeons (p = 0.002). On multivariate logistic regression analyses, CCI ≥ 5 (odds ratio [OR] 6.25, 95% confidence interval [CI] 1.42–27.47; p = 0.015) and surgery by a provider who performed three or fewer cases during the study interval (OR 13.4, 95% CI 2.20–80.89; p = 0.005) were independent predictors for major complications.

Conclusions

High CCI should alert providers to increased probability of major complications, and warrant vigilant management after CUTE. Surgeon volume was inversely related to major postoperative complications.
Literatur
1.
Zurück zum Zitat Ou JH, Pan CC, Lin JS, et al. Transitional cell carcinoma in dialysis patients. Eur Urol. 2000;37(1):90–94.CrossRefPubMed Ou JH, Pan CC, Lin JS, et al. Transitional cell carcinoma in dialysis patients. Eur Urol. 2000;37(1):90–94.CrossRefPubMed
2.
Zurück zum Zitat Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol. 2003;14(1):197–207.CrossRefPubMed Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol. 2003;14(1):197–207.CrossRefPubMed
3.
4.
Zurück zum Zitat Milowsky MI, Rumble RB, Booth CM, et al. Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol. 2016;34(16):1945–52.CrossRefPubMed Milowsky MI, Rumble RB, Booth CM, et al. Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol. 2016;34(16):1945–52.CrossRefPubMed
5.
Zurück zum Zitat Chung PW, Bristow RG, Milosevic MF, et al. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol. 2007;25(4):303–9.CrossRefPubMed Chung PW, Bristow RG, Milosevic MF, et al. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol. 2007;25(4):303–9.CrossRefPubMed
6.
Zurück zum Zitat Roupret M, Babjuk M, Comperat E, et al. European Association of Urology Guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol. 2015;68(5):868–79.CrossRefPubMed Roupret M, Babjuk M, Comperat E, et al. European Association of Urology Guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol. 2015;68(5):868–79.CrossRefPubMed
7.
Zurück zum Zitat Wu CF, Shee JJ, Ho DR, Chen WC, Chen CS. Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma. J Urol. 2004;171(1):126–9.CrossRefPubMed Wu CF, Shee JJ, Ho DR, Chen WC, Chen CS. Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma. J Urol. 2004;171(1):126–9.CrossRefPubMed
8.
Zurück zum Zitat Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol. 2006;176(2):477–81.CrossRefPubMed Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol. 2006;176(2):477–81.CrossRefPubMed
9.
Zurück zum Zitat Tseng SF, Chuang YC, Yang WC. Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma. Int Urol Nephrol. 2011;43(4):1067–71.CrossRefPubMed Tseng SF, Chuang YC, Yang WC. Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma. Int Urol Nephrol. 2011;43(4):1067–71.CrossRefPubMed
10.
Zurück zum Zitat Ou CH, Yang WH. Complete urinary tract exenteration for a dialysis patient with urothelial cancer: lower midline and extraperitoneal approach in a supine position. Urology. 2011;77(5):1244–7.CrossRefPubMed Ou CH, Yang WH. Complete urinary tract exenteration for a dialysis patient with urothelial cancer: lower midline and extraperitoneal approach in a supine position. Urology. 2011;77(5):1244–7.CrossRefPubMed
11.
Zurück zum Zitat Lin VC, Hung KC, Chen MJ, et al. Single-session laparoscopic total urinary tract exenteration without repositioning for multifocal urothelial carcinoma in dialysis-dependent patients. Urology. 2011;77(1):98–103.CrossRefPubMed Lin VC, Hung KC, Chen MJ, et al. Single-session laparoscopic total urinary tract exenteration without repositioning for multifocal urothelial carcinoma in dialysis-dependent patients. Urology. 2011;77(1):98–103.CrossRefPubMed
12.
Zurück zum Zitat Holton MR, Van Zijl PS, Oberle WT, Jacobs SC, Sklar GN. Complete urinary tract extirpation: the University of Maryland experience. Urology. 2006;68(1):65–69.CrossRefPubMed Holton MR, Van Zijl PS, Oberle WT, Jacobs SC, Sklar GN. Complete urinary tract extirpation: the University of Maryland experience. Urology. 2006;68(1):65–69.CrossRefPubMed
13.
Zurück zum Zitat Fang D, Liu P, Li X, et al. Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients. Sci Rep. 2015;5:18014.CrossRefPubMedPubMedCentral Fang D, Liu P, Li X, et al. Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients. Sci Rep. 2015;5:18014.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Ou CH, Yang WH. Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer. Int Urol Nephrol. 2017;49(4):623–7.CrossRefPubMed Ou CH, Yang WH. Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer. Int Urol Nephrol. 2017;49(4):623–7.CrossRefPubMed
15.
Zurück zum Zitat Yossepowitch O, Sagy I, Margel D, Baniel J. Urothelial carcinoma of the bladder in patients on hemodialysis: clinical characteristics and oncological outcomes. J Urol. 2012;187(4):1215–9.CrossRefPubMed Yossepowitch O, Sagy I, Margel D, Baniel J. Urothelial carcinoma of the bladder in patients on hemodialysis: clinical characteristics and oncological outcomes. J Urol. 2012;187(4):1215–9.CrossRefPubMed
16.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Gakis G, Efstathiou J, Lerner SP, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013;63(1):45–57.CrossRefPubMed Gakis G, Efstathiou J, Lerner SP, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013;63(1):45–57.CrossRefPubMed
18.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196.CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196.CrossRefPubMed
19.
Zurück zum Zitat Yuh BE, Nazmy M, Ruel NH, et al. Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy. Eur Urol. 2012;62(5):806–13.CrossRefPubMed Yuh BE, Nazmy M, Ruel NH, et al. Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy. Eur Urol. 2012;62(5):806–13.CrossRefPubMed
20.
Zurück zum Zitat Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349(22):2117–27.CrossRefPubMed Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349(22):2117–27.CrossRefPubMed
21.
Zurück zum Zitat Leow JJ, Reese S, Trinh QD, et al. Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis. BJU Int. 2015;115(5):713–21.CrossRefPubMed Leow JJ, Reese S, Trinh QD, et al. Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis. BJU Int. 2015;115(5):713–21.CrossRefPubMed
22.
Zurück zum Zitat Garg T, Chen LY, Kim PH, Zhao PT, Herr HW, Donat SM. Preoperative serum albumin is associated with mortality and complications after radical cystectomy. BJU Int. 2014;113(6):918–923.CrossRefPubMedPubMedCentral Garg T, Chen LY, Kim PH, Zhao PT, Herr HW, Donat SM. Preoperative serum albumin is associated with mortality and complications after radical cystectomy. BJU Int. 2014;113(6):918–923.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342(23):1686–92.CrossRefPubMed Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342(23):1686–92.CrossRefPubMed
24.
Zurück zum Zitat Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164–74.CrossRefPubMed Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164–74.CrossRefPubMed
25.
Zurück zum Zitat Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med. 2002;137(6):511–20.CrossRefPubMed Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med. 2002;137(6):511–20.CrossRefPubMed
26.
Zurück zum Zitat Roghmann F, Trinh QD, Braun K, et al. Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int J Urol. 2014;21(2):143–9.CrossRefPubMed Roghmann F, Trinh QD, Braun K, et al. Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int J Urol. 2014;21(2):143–9.CrossRefPubMed
27.
Zurück zum Zitat Novara G, De Marco V, Aragona M, et al. Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol. 2009;182(3):914–21.CrossRefPubMed Novara G, De Marco V, Aragona M, et al. Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol. 2009;182(3):914–21.CrossRefPubMed
28.
Zurück zum Zitat Santos F, Zakaria AS, Kassouf W, Tanguay S, Aprikian A. High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec. World J Urol. 2015;33(9):1323–30.CrossRefPubMed Santos F, Zakaria AS, Kassouf W, Tanguay S, Aprikian A. High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec. World J Urol. 2015;33(9):1323–30.CrossRefPubMed
29.
Zurück zum Zitat Mayer EK, Bottle A, Aylin P, Darzi AW, Athanasiou T, Vale JA. The volume-outcome relationship for radical cystectomy in England: an analysis of outcomes other than mortality. BJU Int. 2011;108(8 Pt 2):E258–65.CrossRefPubMed Mayer EK, Bottle A, Aylin P, Darzi AW, Athanasiou T, Vale JA. The volume-outcome relationship for radical cystectomy in England: an analysis of outcomes other than mortality. BJU Int. 2011;108(8 Pt 2):E258–65.CrossRefPubMed
30.
Zurück zum Zitat Lee PC, Chiang YJ, Chen ST. Deceased donor kidney transplantation in Taiwan in 2015. Clin Transpl. 2014:55–59. Lee PC, Chiang YJ, Chen ST. Deceased donor kidney transplantation in Taiwan in 2015. Clin Transpl. 2014:55–59.
31.
Zurück zum Zitat Wu MJ, Lian JD, Yang CR, et al. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis. 2004;43(6):1091–7.CrossRefPubMed Wu MJ, Lian JD, Yang CR, et al. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis. 2004;43(6):1091–7.CrossRefPubMed
Metadaten
Titel
Perioperative Complications and Mortality in Patients with Urothelial Carcinoma and End-Stage Renal Disease Undergoing One-Stage Complete Urinary Tract Extirpation
verfasst von
Yun-Ching Huang, MD, PhD
Ying-Hsu Chang, MD
Alan W. Shindel, MD
Yin-Lun Chang, MD
Jian-Hui Lin, MD
Dong-Ru Ho, MD
Chih-Shou Chen, MD
Publikationsdatum
14.11.2017
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6251-2

Weitere Artikel der Ausgabe 2/2018

Annals of Surgical Oncology 2/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.